Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06379724 · ClinicalTrials.gov registry record · Phase 4
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
A Phase 4 study of Burns and Skin Graft Complications, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT06379724: Recruiting Phase 4 study of Burns and Skin Graft Complications, sponsored by University of Kansas Medical Center.
NCT06379724 is a Phase 4 study of Burns and Skin Graft Complications that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 62 participants, below the 82-participant average among 36 other Burns trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06379724, a Phase 4 study of Burns and Skin Graft Complications, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators hypothesize that topical tranexamic acid will have better or comparable efficacy to topical thrombin in reducing hematoma formation at the wound base. The purpose of the study is to demonstrate that topical tranexamic acid will be a non-inferior alternative medication to the current standard of care,THROMBIN-JMI® , and at a lower cost to the health system.
Primary Outcome
dichotomous endpoint
Conditions Studied
Interventions
- DRUG Tranexamic acid
- DRUG Thrombin JMI
- PROCEDURE skin graft
Study Locations (1)
Kansas
- The University of Kansas Health System - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2024-07-11 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
What NCT06379724 shows while recruiting
NCT06379724 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 82-participant average among 36 other Burns trials with a reported enrollment target (24% lower).
The record links to 2 conditions, with Burns appearing as the primary indexed condition, and to 3 interventions - of which Tranexamic acid is the first listed.
NCT06379724 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06379724 about?
NCT06379724 is a clinical study titled "Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft". Investigators hypothesize that topical tranexamic acid will have better or comparable efficacy to topical thrombin in reducing hematoma formation at the wound base. The purpose of the study is to demonstrate that topical tranexamic acid will be a non-inferior alternative medication to the current st...
What is the current status of trial NCT06379724?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2024-07-11. Estimated completion is 2026-12.
What conditions does trial NCT06379724 study?
This clinical trial studies the following conditions: Burns, Skin Graft Complications.
What interventions are being tested in trial NCT06379724?
The interventions under investigation include: Tranexamic acid (DRUG), Thrombin JMI (DRUG), skin graft (PROCEDURE).
Who is sponsoring clinical trial NCT06379724?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06379724 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06379724's enrollment target sits among peer trials
62 12th of 36 higher than 25 of 36 other Burns trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Burns trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
RECRUITING · Phase 4
-
Microsurfaced Grafts in Deep Burn Wounds
RECRUITING · Phase 4
-
Comparison of Wound Bed Establishment in Facial Burns
COMPLETED · Phase 4
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI